DMX-200

· Dimerix Bioscience Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMX-200, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB [Phase 3]